Translated automatically – community improvements welcome.
Brotizolam
Brotizolam is a short-acting benzodiazepine with sedative, anxiolytic, and muscle-relaxing properties. It acts as a positive allosteric modulator at the GABA-A receptor, which enhances inhibitory neurotransmission in the central nervous system. Due to its pharmacological profile, it is primarily used for the treatment of sleep disorders. The risk of dependence and withdrawal symptoms is increased with prolonged use.
Mechanism of Action
- positive allosteric modulator of GABA-A
Names / Identifiers
IUPAC: Brotizolam
Mechanism of Action
Brotizolam wirkt als Agonist am GABA-A-Rezeptor, was zu einer verstärkten Hemmung der neuronalen Aktivität im zentralen Nervensystem führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Pregnancy
- Sleep apnea
- severe respiratory diseases
Known Risks
- medium
- Mögliche Abhängigkeit und Toleranzentwicklung bei längerem Gebrauch.
Safer Use
- Start with a low dose.
- Avoid alcohol and other sedating substances.
Harm reduction tips do not replace medical advice.
Known Interactions
- Alcohol
- Opioids
- other benzodiazepines
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.
Gemeinsame Wirkungsmuster
Wirkungen, die Brotizolam mit verwandten Substanzen teilt.